Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market: Will Western Europe be Able to Beat the Adoption Rate of North America in the Coming Years?: Global Industry Analysis & Opportunity Assessment (2015 - 2027)

Ask The Analyst Request Advisory

The growing healthcare expenditure provides significant opportunities to hospitals and companies in generating higher revenues. According to the Organization for Economic Cooperation and Development (OECD), the spending on healthcare is estimated to reach US$ 10 trillion by 2020. The healthcare spending in most of the European countries is growing faster than their GDP. According to the U.S. government’s center for Medicare and Medicaid Services (CMS) the healthcare expenditure has risen approximately by 7% and is expected to cross US$ 2 trillion. The Congressional Budget Office states that if the growth in healthcare spending continues at this rate, the CMS spending and private health cost would increase approximately to 25% of the GDP.

For minimizing the healthcare costs and improve the quality of life, countries across the world are seeking to shift the place of care from healthcare facilities to wherever the patients happen to be during their normal day. Half of all the healthcare will take place outside the healthcare facilities within the decade. In many cases, the future of healthcare will be environments such as the home, workplace, school, café, or gym, with the patients responsible for the administration of their therapy. With the typical frequency for a self-injectable biologic ranging from one week to every month or quarter, devices that contain and deliver a drug must be highly intuitive. This trend will continue to accelerate over the next decade, as payers and providers will seek greater access to real-time, cloud-based data that can accurately assess how patients with a chronic disease adhere to their assigned drug regime.

North America will take the lead in the market in the long run with the maximum adoption

Significant focus on shifting to value-based reimbursement model are likely to reduce healthcare costs, which is over 17% of total GDP and health services financing sources witnessing an increase from private sources and decrease in public subsidies is expected to have a major impact on the

Health service providers increasingly collaborating with customers are expected to demonstrate clinical and financial benefit of services and the penetration of artificial intelligence technologies and big data analytics in health technologies, especially for real-time decision making to manage chronic diseases will pave way for future prospects for the market in North America in the near future. Vendors achieving economies of scale by leveraging large customer base and maintaining leading market position are expected to take the market forward in the long run. High geriatric population in the U.S. is anticipated to boost the demand for home healthcare and patient monitoring devices and services in the region and thus, augur well for the market growth in the region.

connected-drug-delivery-devices-market.jpg

Western Europe is expected to closely follow North America in the coming years

Countries such as France, Germany, Italy, and Spain are expected to witness fluctuating demand for connected drug delivery devices in the coming years. France has high potential market but adoption of mobile health is average showing more reluctant to embrace digitalization of healthcare. The implementation of mobile health and related connected drug delivery devices is expected to present considerable challenges, including technological barriers, organizational challenges, confidentiality concerns and unplanned aftereffects. German consumers’ willingness to invest in their well-being and fast data networks is providing fertile ground for mHealth and connected drug delivery devices market growth. Health insurers in Germany have not yet introduced comprehensive reimbursement for m-health applications and connected drug delivery devices, any such strategic changes to acquire larger set of customer will be focused on younger, healthy consumers willing to pay for these services. This might adversely impact the market growth in the region.

Global Healthcare Sector Outlook in Light of the Global Connected Drug Delivery Devices Market

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

  • Current expenditure on health, % of gross domestic product

  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

  • Annual growth rate of current expenditure on health, per capita, in real terms

  • Out-of-pocket expenditure, % of current expenditure on health

  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

  • Physicians, Density per 1000 population (head counts)

  • Nurses, Density per 1000 population (head counts)

  • Total hospital beds, per 1000 population

  • Curative (acute) care beds, per 1000 population

  • Medical technology, Magnetic Resonance Imaging units, total, per million population

  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.

Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Standard Report Structure

  • Executive Summary

  • Market Definition

  • Macro-economic analysis

  • Parent Market Analysis

  • Market Overview

  • Forecast Factors

  • Segmental Analysis and Forecast

  • Regional Analysis

  • Competition Analysis

Market Taxonomy

The global connected drug delivery devices market has been segmented into:

Region

End User

Product Type

Technology

Application

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APECJ

  • China

  • Japan

  • MEA

  • Hospitals

  • Clinics

  • Home Care

  • Inhalation Devices

  • Injectable Devices

    • Handheld Injectable Devices

    • Wearable Injectable Devices

  • Bluetooth

  • Near Field Communication

  • Anaphylaxis

  • Cardiovascular

  • Diabetes

  • Hormone Replacement

  • Others

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

2.3. Market Inclusion and Exclusion

3. Connected Drug Delivery Devices Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Drivers

3.3.1. Supply Side Drivers

3.3.2. Demand Side Drivers

3.4. Restraints

3.5. Trends

4. Global Economic Outlook

4.1. Global Gross Domestic Product by Region & Country

4.2. Global Healthcare Market Indicator

5. North America Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

5.1. Introduction

5.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2027

5.2.1. U.S.

5.2.2. Canada

5.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

5.3.1. Inhalation Devices

5.3.2. Injectable Devices

5.3.2.1. Handheld Injectable Devices

5.3.2.2. Wearable Injectable Devices

5.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

5.4.1. Bluetooth

5.4.2. Near Field Communication

5.5. Market Size (US$ Mn) Forecast By Application, 2015-2027

5.5.1. Anaphylaxis

5.5.2. Cardiovascular

5.5.3. Diabetes

5.5.4. Hormone Replacement

5.5.5. Others

5.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

5.6.1. Hospitals

5.6.2. Clinics

5.6.3. Homecare

5.7. Market Attractiveness Analysis

5.7.1. By Product Type

5.7.2. Technology

5.7.3. By Application

5.7.4. By End User

5.7.5. By Country

5.8. Drivers and Restraints: Impact Analysis

5.9. Key Market Participants – Intensity Mapping

6. Latin America Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

6.1. Introduction

6.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2027

6.2.1. Brazil

6.2.2. Mexico

6.2.3. Argentina

6.2.4. Rest of Latin America

6.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

6.3.1. Inhalation Devices

6.3.2. Injectable Devices

6.3.2.1. Handheld Injectable Devices

6.3.2.2. Wearable Injectable Devices

6.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

6.4.1. Bluetooth

6.4.2. Near Field Communication

6.5. Market Size (US$ Mn) Forecast By Application, 2015-2027

6.5.1. Anaphylaxis

6.5.2. Cardiovascular

6.5.3. Diabetes

6.5.4. Hormone Replacement

6.5.5. Others

6.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

6.6.1. Hospitals

6.6.2. Clinics

6.6.3. Homecare

6.7. Market Attractiveness Analysis

6.7.1. By Product Type

6.7.2. Technology

6.7.3. By Application

6.7.4. By End User

6.7.5. By Country

6.8. Drivers and Restraints: Impact Analysis

6.9. Key Market Participants – Intensity Mapping

7. Western Europe Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

7.1. Introduction

7.2. Market Size (US$ Mn) Forecast By Country, 2015-2027

7.2.1. Germany

7.2.2. U.K

7.2.3. France

7.2.4. Italy

7.2.5. Spain

7.2.6. Rest of Western Europe

7.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

7.3.1. Inhalation Devices

7.3.2. Injectable Devices

7.3.2.1. Handheld Injectable Devices

7.3.2.2. Wearable Injectable Devices

7.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

7.4.1. Bluetooth

7.4.2. Near Field Communication

7.5. Market Size (US$ Mn) Forecast By Application, 2015-2027

7.5.1. Anaphylaxis

7.5.2. Cardiovascular

7.5.3. Diabetes

7.5.4. Hormone Replacement

7.5.5. Others

7.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

7.6.1. Hospitals

7.6.2. Clinics

7.6.3. Homecare

7.7. Market Attractiveness Analysis

7.7.1. By Product Type

7.7.2. Technology

7.7.3. By Application

7.7.4. By End User

7.7.5. By Country

7.8. Drivers and Restraints: Impact Analysis

7.9. Key Market Participants – Intensity Mapping

8. Eastern Europe Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

8.1. Introduction

8.2. Market Size (US$ Mn) Forecast By Country, 2015-2027

8.2.1. Russia

8.2.2. Poland

8.2.3. Rest of Eastern Europe

8.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

8.3.1. Inhalation Devices

8.3.2. Injectable Devices

8.3.2.1. Handheld Injectable Devices

8.3.2.2. Wearable Injectable Devices

8.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

8.4.1. Bluetooth

8.4.2. Near Field Communication

8.5. Market Size (US$ Mn) Forecast By Application, 2015-2027

8.5.1. Anaphylaxis

8.5.2. Cardiovascular

8.5.3. Diabetes

8.5.4. Hormone Replacement

8.5.5. Others

8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

8.6.1. Hospitals

8.6.2. Clinics

8.6.3. Homecare

8.7. Market Attractiveness Analysis

8.7.1. By Product Type

8.7.2. Technology

8.7.3. By Application

8.7.4. By End User

8.7.5. By Country

8.8. Drivers and Restraints: Impact Analysis

8.9. Key Market Participants – Intensity Mapping

9. Asia Pacific Excluding China & Japan Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

9.1. Introduction

9.2. Market Size (US$ Mn) Forecast By Country, 2015-2027

9.2.1. India

9.2.2. Australia and New Zealand

9.2.3. ASEAN

9.2.4. Rest of APECJ

9.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

9.3.1. Inhalation Devices

9.3.2. Injectable Devices

9.3.2.1. Handheld Injectable Devices

9.3.2.2. Wearable Injectable Devices

9.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

9.4.1. Bluetooth

9.4.2. Near Field Communication

9.5. Market Size (US$ Mn) Forecast By Application, 2015-2027

9.5.1. Anaphylaxis

9.5.2. Cardiovascular

9.5.3. Diabetes

9.5.4. Hormone Replacement

9.5.5. Others

9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

9.6.1. Hospitals

9.6.2. Clinics

9.6.3. Homecare

9.7. Market Attractiveness Analysis

9.7.1. By Product Type

9.7.2. Technology

9.7.3. By Application

9.7.4. By End User

9.7.5. By Country

9.8. Drivers and Restraints: Impact Analysis

9.9. Key Market Participants – Intensity Mapping

10. China Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

10.1.Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

10.2.1. Inhalation Devices

10.2.2. Injectable Devices

10.2.2.1. Handheld Injectable Devices

10.2.2.2. Wearable Injectable Devices

10.3. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

10.3.1. Bluetooth

10.3.2. Near Field Communication

10.4. Market Size (US$ Mn) Forecast By Application, 2015-2027

10.4.1. Anaphylaxis

10.4.2. Cardiovascular

10.4.3. Diabetes

10.4.4. Hormone Replacement

10.4.5. Others

10.5. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

10.5.1. Hospitals

10.5.2. Clinics

10.5.3. Homecare

10.6. Market Attractiveness Analysis

10.6.1. By Product Type

10.6.2. Technology

10.6.3. By Application

10.6.4. By End User

10.7. Drivers and Restraints: Impact Analysis

10.8.Key Market Participants – Intensity Mapping

11. Japan Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

11.1.Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

11.2.1. Inhalation Devices

11.2.2. Injectable Devices

11.2.2.1. Handheld Injectable Devices

11.2.2.2. Wearable Injectable Devices

11.3. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

11.3.1. Bluetooth

11.3.2. Near Field Communication

11.4. Market Size (US$ Mn) Forecast By Application, 2015-2027

11.4.1. Anaphylaxis

11.4.2. Cardiovascular

11.4.3. Diabetes

11.4.4. Hormone Replacement

11.4.5. Others

11.5. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

11.5.1. Hospitals

11.5.2. Clinics

11.5.3. Homecare

11.6. Market Attractiveness Analysis

11.6.1. By Product Type

11.6.2. Technology

11.6.3. By Application

11.6.4. By End User

11.7. Drivers and Restraints: Impact Analysis

11.8. Key Market Participants – Intensity Mapping

12. Middle East and Africa Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027

12.1. Introduction

12.2. Regional Market Trends

12.3. Market Size (US$ Mn) Forecast By Country, 2015-2027

12.3.1. GCC Countries

12.3.2. South Africa

12.3.3. Rest of Middle East and Africa

12.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027

12.4.1. Inhalation Devices

12.4.2. Injectable Devices

12.4.2.1. Handheld Injectable Devices

12.4.2.2. Wearable Injectable Devices

12.5. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017

12.5.1. Bluetooth

12.5.2. Near Field Communication

12.6. Market Size (US$ Mn) Forecast By Application, 2015-2027

12.6.1. Anaphylaxis

12.6.2. Cardiovascular

12.6.3. Diabetes

12.6.4. Hormone Replacement

12.6.5. Others

12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027

12.7.1. Hospitals

12.7.2. Clinics

12.7.3. Homecare

12.8. Market Attractiveness Analysis

12.8.1. By Product Type

12.8.2. Technology

12.8.3. By Application

12.8.4. By End User

12.8.5. By Country

12.9. Drivers and Restraints: Impact Analysis

12.10. Key Market Participants – Intensity Mapping

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis

15.1.Market Structure by Tier

15.2.Market Share Analysis (2016) for Top Players, By Region

16. Competition Analysis

16.1.Competition Dashboard

16.2.Competitors Deep Dive

16.2.1. Bayer AG

16.2.1.1. Overview

16.2.1.2. Product and Application Portfolio

16.2.1.3. Production Footprint

16.2.1.4. Sales Footprint

16.2.1.5. Channel Footprint

16.2.1.6. Strategy

16.2.1.6.1. Marketing Strategy

16.2.1.6.2. Product Strategy

16.2.1.6.3. Channel Strategy

16.2.2. Propeller Health

16.2.2.1. Overview

16.2.2.2. Product and Application Portfolio

16.2.2.3. Production Footprint

16.2.2.4. Sales Footprint

16.2.2.5. Channel Footprint

16.2.2.6. Strategy

16.2.2.6.1. Marketing Strategy

16.2.2.6.2. Product Strategy

16.2.2.6.3. Channel Strategy

16.2.3. West Pharmaceutical Services, Inc.

16.2.3.1. Overview

16.2.3.2. Product and Application Portfolio

16.2.3.3. Production Footprint

16.2.3.4. Sales Footprint

16.2.3.5. Channel Footprint

16.2.3.6. Strategy

16.2.3.6.1. Marketing Strategy

16.2.3.6.2. Product Strategy

16.2.3.6.3. Channel Strategy

16.2.4. 3M Company

16.2.4.1. Overview

16.2.4.2. Product and Application Portfolio

16.2.4.3. Production Footprint

16.2.4.4. Sales Footprint

16.2.4.5. Channel Footprint

16.2.4.6. Strategy

16.2.4.6.1. Marketing Strategy

16.2.4.6.2. Product Strategy

16.2.4.6.3. Channel Strategy

16.2.5. OPKO Health

16.2.5.1. Overview

16.2.5.2. Product and Application Portfolio

16.2.5.3. Production Footprint

16.2.5.4. Sales Footprint

16.2.5.5. Channel Footprint

16.2.5.6. Strategy

16.2.5.6.1. Marketing Strategy

16.2.5.6.2. Product Strategy

16.2.5.6.3. Channel Strategy

16.2.6. Sagentia (Science Group)

16.2.6.1. Overview

16.2.6.2. Product and Application Portfolio

16.2.6.3. Production Footprint

16.2.6.4. Sales Footprint

16.2.6.5. Channel Footprint

16.2.6.6. Strategy

16.2.6.6.1. Marketing Strategy

16.2.6.6.2. Product Strategy

16.2.6.6.3. Channel Strategy

16.2.7. Cohero Health

16.2.7.1. Overview

16.2.7.2. Product and Application Portfolio

16.2.7.3. Production Footprint

16.2.7.4. Sales Footprint

16.2.7.5. Channel Footprint

16.2.7.6. Strategy

16.2.7.6.1. Marketing Strategy

16.2.7.6.2. Product Strategy

16.2.7.6.3. Channel Strategy

16.2.8. Care TRx

16.2.8.1. Overview

16.2.8.2. Product and Application Portfolio

16.2.8.3. Production Footprint

16.2.8.4. Sales Footprint

16.2.8.5. Channel Footprint

16.2.8.6. Strategy

16.2.8.6.1. Marketing Strategy

16.2.8.6.2. Product Strategy

16.2.8.6.3. Channel Strategy

16.2.9. CeQur SA

16.2.9.1. Overview

16.2.9.2. Product and Application Portfolio

16.2.9.3. Production Footprint

16.2.9.4. Sales Footprint

16.2.9.5. Channel Footprint

16.2.9.6. Strategy

16.2.9.6.1. Marketing Strategy

16.2.9.6.2. Product Strategy

16.2.9.6.3. Channel Strategy

16.2.10. Biocorp Production SA

16.2.10.1. Overview

16.2.10.2. Product and Application Portfolio

16.2.10.3. Production Footprint

16.2.10.4. Sales Footprint

16.2.10.5. Channel Footprint

16.2.10.6. Strategy

16.2.10.6.1. Marketing Strategy

16.2.10.6.2. Product Strategy

16.2.10.6.3. Channel Strategy

17. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Region

17.1. Introduction / Key Findings

17.2. Market Size (US$ Mn) Forecast By Region

17.2.1. North America

17.2.2. Western Europe

17.2.3. Eastern Europe

17.2.4. Latin America

17.2.5. Asia Pacific Excluding Japan And China

17.2.6. China

17.2.7. Japan

17.2.8. Middle East and Africa

17.3. Market Attractiveness Analysis By Region

18. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Product Type

18.1. Introduction/Key Finding

18.2. Market Size (US$ Mn) Forecast By Product Type, 2015-2027

18.2.1. Inhalation Devices

18.2.2. Injectable Devices

18.2.2.1. Handheld Injectable Devices

18.2.2.2. Wearable Injectable Devices

18.3. Market Attractiveness Analysis By Product Type

19. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Technology

19.1. Introduction/Key Finding

19.2. Market Size (US$ Mn) Forecast By Technology, 2015-2027

19.2.1. Bluetooth

19.2.2. Near Field Communication

19.3. Market Attractiveness Analysis By Technology

20. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Application

20.1. Introduction/Key Finding

20.2. Market Size (US$ Mn) Forecast By Application, 2015-2027

20.2.1. Anaphylaxis

20.2.2. Cardiovascular

20.2.3. Diabetes

20.2.4. Hormone Replacement

20.2.5. Others

20.3. Market Attractiveness Analysis By Application

21. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By End User

21.1. Introduction/Key Finding

21.2.Market Size (US$ Mn) Forecast By End User, 2015-2027

21.2.1. Hospitals

21.2.2. Clinics

21.2.3. Homecare

21.3.Market Attractiveness Analysis By End User

22. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027

22.1.Market Value Share Analysis By All Segment

22.2.Y-o-Y Growth Analysis By All Segment

22.3.Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Table 01: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country

Table 02: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 03: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 04: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 05: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 06: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country

Table 07: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 08: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 09: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 10: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 11: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country

Table 12: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 13: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 14: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 15: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 16: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country

Table 17: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 18: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 19: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 20: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 21: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country

Table 22: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 23: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 24: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 25: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 26: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 27: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 28: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 29: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 30: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 31: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 32: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 33: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 34: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country

Table 35: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type 

Table 36: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology

Table 37: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application

Table 38: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User

Table 39: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Region 

Table 40: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2027, By Product Type

Table 41: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology 

Table 42: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2027, By Application

Table 43: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis-and Opportunity Assessment 2015–2027, By End User

Figure 01: North America Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 02: North America Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 03: North America Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 03: North America Connected Drug Delivery Devices Market Value Share By Country (2017 E)

Figure 04: North America Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 06: North America Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 07: U.S. Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 08: Canada Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 08: Western Europe Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 09: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 10: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 11: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 12: North America Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 13: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027

Figure 14: Latin America Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 15: Latin America Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 16: Latin America Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 17: Latin America Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 18: Latin America Connected Drug Delivery Devices Market Value Share By Country (2017 E)

Figure 19: Latin America Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 20: Brazil Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 21: Mexico Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 22: Argentina Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 23: Rest of Latin America Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 24: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 25: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 26: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 27: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 28: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027

Figure 29: Western Europe Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 30: Western Europe Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 31: Western Europe Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 32: Western Europe Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 33: Western Europe Connected Drug Delivery Devices Market Value Share By Country (2017 E)

Figure 34: U.K. Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 35: Germany Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 36: France Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 37: Italy Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 38: Spain Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 39: Rest of Western Europe Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 40: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 41: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 42: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 43: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 44: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027

Figure 45: Eastern Europe Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 46: Eastern Europe Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 47: Eastern Europe Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 48: Eastern Europe Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 49: Eastern Europe Connected Drug Delivery Devices Market Value Share By Country (2017 E)

Figure 50: Eastern Europe Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 51: Russia Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 52: Poland Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 53: Rest of Eastern Europe Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 54: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 55: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 56: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 57: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 58 : Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027

Figure 59: APECJ Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 60: APECJ Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 61: APECJ Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 62: APECJ Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 63: APECJ Connected Drug Delivery Devices Market Value Share By Country (2017 E)

Figure 64: APECJ Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 65: India Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 66: ANZ Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 67: ASEAN Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 68: Rest of APECJ Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 69: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 70: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 71: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 72: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 73: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027

Figure 74: China Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 75: China Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 76: China Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 77: China Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 78: China Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 79: China Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 80: China Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 81: China Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 82: China Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 83: Japan Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 84: Japan Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 85: Japan Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 86: Japan Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 87: Japan Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 88: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 89: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 90: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 91: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 91: MEA Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)

Figure 92: MEA Connected Drug Delivery Devices Market Value Share By Technology (2017 E)

Figure 93: MEA Connected Drug Delivery Devices Market Value Share By Country (2017 E)

Figure 94: MEA Connected Drug Delivery Devices Market Value Share By Application (2017 E)

Figure 95: MEA Connected Drug Delivery Devices Market Value Share By End User (2017 E)

Figure 96: MEA Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027

Figure 97: South Africa Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 98: GCC Countries Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 100: Rest of MEA Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027

Figure 101: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 102: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 103: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 104: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 105: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027

Figure 106: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Region, 2017-2027

Figure 107: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Inhalation Devices

Figure 108: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Injectable Devices

Figure 109: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027

Figure 110: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Bluetooth

Figure 111: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By NFC

Figure 112: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027

Figure 113: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Anaphylaxis

Figure 114: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Cardiovascular

Figure 115: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Diabetes

Figure 116: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Hormone Replacement

Figure 117: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Others

Figure 118: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027

Figure 119: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Hospitals

Figure 120: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Clinics

Figure 121: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Homecare

Figure 122: Global Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027

Figure 123: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015-2027

Figure 124: Global Connected Drug Delivery Devices Market Absolute $ Opportunity, 2017 - 2027